Vanguard Group Inc Roivant Sciences Ltd. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 41,683,055 shares of ROIV stock, worth $522 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,683,055
Previous 8,191,824
408.84%
Holding current value
$522 Million
Previous $86.6 Million
455.54%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$826 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$824 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$678 Million2.42% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$443 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.7MShares$372 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.83B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...